You are here

  • Home
  • Archive
  • Volume 106, Issue 10
  • Next-generation sequencing as a clinical laboratory tool for describing different microbiotas: an urgent need for future paediatric practice

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Next-generation sequencing as a clinical laboratory tool for describing different microbiotas: an urgent need for future paediatric practice

https://doi.org/10.1136/archdischild-2021-321683

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @PaedsRH

    • Collaborators Gut Microbiota for Health expert panel of British Society of Gastroenterology.

    • Contributors All authors contributed equally.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests RH has received consultancy fees and conference travel support from 4D Pharma and Nutricia. GLH has received consultancy fees and conference travel support from Ferring and Proctor & Gamble. GLH is also a member of Enterobiotix scientific advisory panel. KG has received research grants, speaker’s and consultancy fees from Nestle Health Science, Nutricia-Danone, Mylan, Abbott and Baxter. THI has received speaker’s fees from Vifor, Pharmacosmosos, Shield, Takeda, Roche and Ferring. JRM has received consultancy fees from Enterobiotix.

    • Provenance and peer review Not commissioned; internally peer reviewed.